MHC-Ib proteins primarily function to inhibit immune responses. 7 For example, the human MHC-Ib protein human leukocyte antigen (HLA)-E inhibits natural killer cells. 8, 9 During pregnancy, HLA-G inhibits both T cells and natural killer cells to provide an immunologically favorable environment at the maternal-fetal interface that protects the conceptus from the maternal immune system. 6, 10, 11 HLA-G is also thought to contribute to immune evasion of tumour cells, 9, 12 and blocking HLA-G with a specific antibody may offer an innovative therapeutic strategy for cancer. 13 In cattle, MHC-I genes are abundantly expressed in lymphocytes, but expression in placental trophoblast cells is very low, particularly during the first two trimesters of pregnancy. 14 Abnormally high expression of MHC-I in placental trophoblast is linked to a higher rate of miscarriage in somatic cell nuclear transfer (SCNT) pregnancies. 15 Moreover, MHC-Ia and -Ib genes are differentially expressed among various tissues in cattle. Microarray screening in bovine peripheral blood mononuclear cells (PBMC) showed that MHC-Ia accounted for more than 90% of total MHC-I transcripts, whereas in bovine placental trophoblast cells, (PTC) MHC-Ia and -Ib accounted for 22% to 66% and 34% to 79% of total transcripts, respectively. 
16). Important cis-regulatory elements that regulate MHC-I expression
include enhancer A, 17 interferon (IFN)-stimulated regulatory element, 18 and the SXY module, 19, 20 which are bound by nuclear factor kappa-lightchain-enhancer of activated B cells (NF-κB), interferon regulatory factor 1 (IRF1) and MHC class II (MHC-II) enhanceosome A, respectively. [17] [18] [19] [20] Regulation of MHC-I genes by cytokines and inflammatory factors, such as interferon gamma (IFN-γ), 21 transforming growth factor beta (TGF-β), 22 and tumour necrosis factor alpha (TNFα), 23 can partially explain differences in MHC-I expression patterns among tissues. However, the extremely different transcription patterns for MHC-Ia and -Ib genes in bovine PBMC and PTC suggests that other mechanisms, such as epigenetic regulation, may also be involved in controlling expression of MHC-I genes in cattle.
Methylation of cytosine residues at CpG dinucleotides is one of the best-studied epigenetic modifications in the mammalian genome and is known to have a prominent effect on gene expression. 24 DNA hypermethylation silences the expression of HLA-A and HLA-B in certain cancers, 25 and demethylation treatment induces the expression of HLA-G. 26 Suarez-Alvarez et al demonstrated that promoter methylation plays a very important role in regulating the expression of MHC-I in human embryonic stem cells. 27 The objective of this study was to elucidate the regulatory mecha- 
| MATERIALS AND METHODS

| Animals
| Isolation and culture of PTC
| Quantitative reverse transcription polymerase chain reaction (qRT-PCR)
Total RNA from PBMC, and day 35 AI and SCNT PTC were isolated using an Ambion PureLink RNA mini isolation kit (Life Technologies, Carlsbad, CA). First-strand cDNA from each sample was generated from 1 μg total RNA using the SuperScript VILO cDNA synthesis kit 30 Quantitative PCR data were analyzed using the formula for relative quantification described by Pfaffl. 31 The relative mRNA levels were normalized to GAPDH mRNA levels.
| DNA sequencing of MHC-I CpG islands
Genomic DNA from PBMC and PTC was extracted using the Purelink 
BoLA, bovine leukocyte antigen; CIITA, class II MHC transactivator; MHC, major histocompatibility complex.
| Bisulfite-sequencing of MHC-I CpG islands
To determine the methylation status of the MHC-I CpG island regions in PBMC and PTC, 1 μg genomic DNA from each sample was bisulfitetreated using the EZ DNA Methylation-Gold Kit (Zymo Research, Irvine, CA) according to the manufacturer's recommended protocol.
Because methylation-specific PCR is inefficient for reactions generating products longer than 500 bps, the MHC-I genetic region containing the CpG islands was split into four fragments. Specific primers for each genomic DNA fragment were designed using Methprimer 32 and primer sequences are provided in Table 2 . Roche 454 sequencing was performed as previously described, 33 with minor modifications. Two PCR steps were performed to produce amplicons for 454 sequencing. First, primer pairs with MHC-I-specific sequence and flanking adaptor sequence were used to amplify CpG island fragments from bisulfite-treated genomic DNA; the cycling parameters were 94°C for Sequencing reads were analyzed using DNASTAR Lasergene software (Madison, WI).
| Statistical analysis
Quantitative PCR data were analyzed using the relative quantification method described by Pfaffl. 31 For each sample, the percentage of each MHC-I gene, or gene subset in the case of MHC-Ia, was based on the relative abundance compared to glyceraldehyde-3-phosphate dehydrogenase (GAPDH), the internal control. The abundance was calculated using the
.
The percentage of MHC-X in each sample was obtained using the for-
All statistical analyses were performed using R software. One-way ANOVA with a Bonferroni post-hoc test for multiple group comparisons was performed to determine significance. A probability of P < .05
was considered statistically significant.
| RESULTS
| Expression of MHC-I is regulated by transcription factors
Expression of all MHC-I subtypes was significantly higher in PBMC than in PTC from AI or SCNT pregnancies (P < .001; Table 3 ).
Expression of MHC-I subtypes was also significantly higher in SCNT PTC than in AI PTC. The transcription factor genes interferon regulatory factor 1 (IRF1) and signal transducer and activator of transcription 1 (STAT1), and the transcriptional coactivator gene class II MHC transactivator (CIITA) showed a similar expression pattern to MHC-I.
Expression of nuclear factor kappa B subunit 1 (NFKB1; previously known as NFκB p50), RELA proto-oncogene (RELA; previously known as NFκB p65) and regulatory factor X5 (RFX5) was significantly higher in PBMC compared to PTC, while expression of these transcription factors did not differ in AI and SCNT PTC. No significant difference in the expression of transcription factor genes cyclic-AMP responsive element binding protein 1 (CREB1), regulatory factor X-associated protein (RFXAP) and nuclear transcription factor Y subunit gamma (NFYC) was observed among the groups ( Figure 1 and Table 3 ). Expression of T A B L E 2 Primers for major histocompatibility complex (MHC)-I CpG island DNA sequencing and 454 methylation sequencing (Table 4) . Table 5 ).
| Expression of
| Methylation of CpG islands in MHC-Ia and MHC-Ib genes
The DNA sequences of six MHC-I reference alleles were retrieved from GenBank (NW_001494163). In silico analysis (http://www.urogene.org/cgi-bin/methprimer/methprimer.cgi) identified a CpG island of approximately 1500 bp spanning from approximately 300 bp upstream of the transcription start site to the third exon in each bovine MHC-I gene ( Figure 3A ). Methylation status of these CpG islands was determined by bisulfite conversion followed by sequencing on a 454 GS FLX+ sequencer. Information about the sequencing reads from four PBMC samples is provided in Table 6 , and information about the sequencing reads from two AI PTC and two SCNT PCT samples is presented in Mean values were calculated using GAPDH as an internal control. The fold change in gene expression for each PTC and peripheral blood mononuclear cells (PBMC) sample was calculated with respect to the mean value for the artificial insemination (AI) PTC samples (AI PTC n = 5; somatic cell nuclear transfer [SCNT] PTC n = 5; PBMC n = 3). Statistical comparisons between groups were performed using one-way ANOVA with the Bonferroni post-hoc test. ns, not significant; BoLA, bovine leukocyte antigen; CIITA, class II MHC transactivator; PTC, placental trophoblast cells. *P < .05. **P < .01. ***P < .001. 
| Expression of DNA methyltransferase (DNMT) isoforms
DNA methylation is catalyzed and maintained by three DNA methyltransferases: DNMT1, DNMT3A, and DNMT3B. 34 Expression of the three DNA methyltransferase genes in PBMC, AI, and SCNT PTC were measured by qRT-PCR ( Figure 5 ). Both DNMT1 and DNMT3A were expressed at a similar level among all groups. However, expression of DNMT3B was significantly lower in PBMC than that in either AI or SCNT PTC. Expression of DNMT3B in SCNT PTC was lower than in AI PTC, but the difference was not statistically significant.
| Demethylation of MHC-Ib genes in PBMC
To test whether bovine MHC-I expression can be affected by demethylation, PBMC and AI PTC were cultured in medium containing 100 μmol/L 5′-aza-2-deoxycytindine for 3 days to reduce overall methylation, and these cells were compared to cells cultured without For each sample, the percentage of each major histocompatibility complex (MHC)-I gene, or gene subset in the case of MHC-Ia, was calculated from the relative abundance compared to GAPDH, the internal control, as described in the methods section. 31 The percentage of each subtype in each cell type is the mean value for all of the animals in the group (AI PTC n = 7; somatic cell nuclear transfer [SCNT] PTC n = 5; PBMC n = 3). Statistical comparisons between groups were performed using one-way ANOVA with the Bonferroni post-hoc test for multiple comparisons. ns, not significant; BoLA, bovine leukocyte antigen; PBMC, peripheral blood mononuclear cells; PTC, placental trophoblast cells. *P < .05. **P < .01. ***P < .001. 
T A B L E 4 Pearson correlation coefficients between major histocompatibility complex (MHC)-I expression and transcription factor expression
F I G U R E 2 Major histocompatibility complex (MHC)-Ia and MHCIb transcript percentages in placental trophoblast cells (PTC) and peripheral blood mononuclear cells (PBMC). Expression of MHC-Ia
5′-aza-2-deoxycytindine. Expression of each MHC-I
| DISCUSSION
In this study, we analyzed of the expression of mRNA for transcription factors associated with MHC-I expression in bovine PTC and PBMC.
Our results indicated that in comparison with PTC, PBMC express relatively high levels of mRNA for MHC-I transcription factors IRF1, CIITA, NFKB1 and RELA, and the cell signaling gene STAT1 (Table 3) .
In other studies, these transcription factors have been shown to induce MHC-I expression in humans and other mammals. [16] [17] [18] [19] [20] The ability of these transcription factors to induce MHC-I expression in bovine AI, artificial insemination; BoLA, bovine leukocyte antigen; SCNT, somatic cell nuclear transfer. for the co-existence of Th1 and Th2 characteristics in this special subpopulation of CD4 + T cells. 43 Huang et al showed expression of the insulin-like growth factor two (IGF2) gene was negatively regulated by intragenic DNA methylation in cattle. 44 In this study, we observed that the methylated BoLA-NC2, -NC3, and -NC4 genes in PBMC con- and -NC4 genes characterized in this study. stage. 51 However, DNA demethylation occurred only at the one-cell stage in SCNT embryos. 51 As DNMT genes are expressed at a similar level in both types of PTC, the higher DNA methylation level of the BoLA-NC2, -NC3, and -NC4 genes in SCNT PTC is probably caused by insufficient DNA demethylation during embryogenesis.
In conclusion, our study suggests that bovine MHC-I expression is regulated by both genetic and epigenetic factors. Expression of the 
MHC-I
